GlaxoSmithKline has reportedly worked in recent months to shake up its antibiotics business after at least one failed attempt to divest products. Now, dozens of GSK employees could wind up on the cutting room floor as the drugmaker shifts away from producing a key antibiotic component. The British drugmaker will look to trim positions at… Read More »
Outside of vaccines, GlaxoSmithKline isn’t a major producer of biologics compared with some of its Big Pharma peers. But it has just signed a big deal to scale up manufacturing in the field. The British pharma tapped South Korean CDMO Samsung Biologics in a deal worth more than $ 231 million to help it make biologic… Read More »
GlaxoSmithKline has been working to unload its Indian consumer products business, including the nutritional beverage Horlicks, and now the company may be almost there. Following a monthslong bidding process that in October reportedly centered on potential buyers Nestlé, Coca-Cola and Unilever, Unilever is now the leading bidder, Reuters reports. While the Financial Times reported on Tuesday that the… Read More »